Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Nocturnal enuresis is a condition, which can affectthe quality of life in children. The present study was designed toinvestigate the efficacy of low-dose imipramine combined withdesmopressin on treatment of patients with primary nocturnalenuresis who were defined as desmopressin non-responders.
Methods: A randomized clinical trial was carried out on patientswith primary nocturnal enuresis. Forty children with enuresisranging from 5 to 12 years old were randomly divided into theintervention (n = 20) and control groups (n = 20). The subjects inthe intervention group were treated with desmopressin combinedwith 5 mg imipramine at bedtime, and those in the control groupwere given desmopressin alone. The patients were followed upweekly for one month. The number of wet nights was recorded.
Results: Two individuals in the intervention and three individualsin the control group were excluded from the study. Our findingsindicated that the age and gender showed no significant difference.Furthermore, a significant better recovery in the enuresis wasobserved in 18 of 20 patients who were treated with combinationtherapy after 1 month (P < .05). In addition, the frequency ofrecovery was significantly higher (83.3%) in the intervention group,compared with the control group (29.4%).
Conclusion: The analysis showed that low-dose imipramine is welltolerated in clinical practice and may represent a good short-termtreatment option in combination therapy where desmopressinalone is not efficient enough.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Regional Genetic Study: Monosymptomatic Nocturnal Enuresis and Array Technology.
Urol J
September 2025
Department of Child and Adolescent Psychiatry, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, TURKIYE.
Purpose: This study aimed to investigate the genetic heterogeneity of primary monosymptomatic nocturnal enuresis (PMNE) and assess potential genetic variants contributing to its etiology.
Materials And Methods: A total of 92 children aged 5-15 years with a positive family history of PMNE were evaluated. All patients underwent detailed urological and nephrological assessments to exclude organic causes.
Worsening of primary nocturnal enuresis due to Graves' disease in a child.
Pediatr Int
January 2025
Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.
When Nonspecific Symptoms Conceal Kidney Disease: A Case Report on Recognizing Juvenile Nephronophthisis in Pediatric Practice.
J Pediatr Health Care
September 2025
Vinay Kukreti, MD, Staff Pediatrician, Lakeridge Health, Pediatrics, Oshawa, ON, Canada; Associate Professor, School of Medicine, Pediatrics, Queen's University, Kingston, ON, Canada. Electronic address:
Juvenile nephronophthisis (NPHP) is the most common genetic cause of pediatric chronic kidney disease (CKD). Its nonspecific findings such as intermittent fatigue, nausea, or vomiting, often delay diagnosis, especially without extra-renal manifestations. This case study reports a 9-year-old boy with a week of acute-on-chronic vomiting, a year of nausea and fatigue, and new onset polydipsia and nocturnal enuresis.
View Article and Find Full Text PDFSevere Elimination Disorders and Normal Intelligence in a Case of Related Syndrome: A Case Report.
Genes (Basel)
July 2025
División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico.
Pathogenic variants in the gene have been associated with neurological impairment, including intellectual disability, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, brain malformations, cognitive hearing loss, short stature, and dysmorphic features. However, few cases with detailed clinical characterization have been reported. We describe a 12-year-old boy carrying a loss-of-function variant, presenting with severe elimination disorders despite normal intelligence.
View Article and Find Full Text PDFObjectives: To assess the predictive factors for relapse in pediatric patients with primary monosymptomatic nocturnal enuresis following the use desmopressin oral lyophilisate.
Methods: A prospective cohort study was conducted from 2018 to 2025. We evaluated whether patient age and gender, compliance, method of therapy discontinuation, and other parameters affected relapse occurrence.